Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ling Yui Holdings Limited ( (HK:0784) ) has provided an announcement.
Ling Yui Holdings Limited has undergone a change of control after Hapbiotech Investment Holding Limited agreed to purchase 560,140,000 shares, representing 70.02% of its issued share capital, at HK$0.2375 per share. Completion of this transaction occurred on 9 April 2026, giving the offeror and parties acting in concert majority ownership of the company.
Following the acquisition, Hapbiotech is required under Hong Kong’s Takeovers Code to make an unconditional mandatory cash offer for all remaining shares it does not already own, at the same price of HK$0.2375 per share. The move, which will be executed through Red Sun Capital as financial adviser, signals a potential shift in strategic direction and governance for Ling Yui’s minority shareholders as control consolidates under the new owner.
More about Ling Yui Holdings Limited
Ling Yui Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 784. The announcement centres on changes to its shareholding and control structure, although the specific business operations and industry focus of the group are not described in the release.
Average Trading Volume: 3,000,576
Technical Sentiment Signal: Buy
Current Market Cap: HK$288M
Learn more about 0784 stock on TipRanks’ Stock Analysis page.